This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough.
Share this article
Corporate
Score 75
Bullish
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
Mar 13, 2026 14:11 UTC
AMGN, VRTX, BMY, XLV
Short term
Related Articles
Score 35
Paramount's 30-Film Annual Slate Targets 2027 Box Office Dominance
Mar 14, 11:00
Score 75
Bullish
JSW Steel Wins Rights to Develop Coking Coal Mine in Mozambique
Mar 14, 06:13
Score 35
Uber ex-CEO Kalanick rebrands latest venture Atoms, expands into mining and transport
Mar 13, 22:04
Score 45
LSEG Plans Up to $3 Billion Bond Sale Next Week
Mar 13, 21:33
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.